Real-world first-line serplulimab-based immunochemotherapy for extensive-stage small cell lung cancer: The multicenter ASTRUM-005R study.

被引：0
|
作者：
Wu, Lin
Hu, ChengPing
Su, Wenzhong
Yu, Yan
Hong, Wei
Liu, Zhigang
Su, Haichuan
Liu, Zhentian
Wang, Caixia
Pu, Qing
Guo, Hui, Sr.
Min, Xuhong
Chen, Yifei
机构：
[1] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Thorac Med Oncol,Xiangya Sch Med, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Resp & Crit Care Med, Changsha, Hunan, Peoples R China
[3] Shanxi Med Univ, Shanxi Canc Hosp, Canc Hosp, Shanxi Canc Inst,Affiliated Hosp,Shanxi Hosp,Chin, Taiyuan, Peoples R China
[4] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[5] Univ Chinese Acad Sci, Canc Hosp, Dept Chest Oncol, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[6] Southern Med Univ, Affiliated Hosp 10, Ctr Canc, Dongguan Peoples Hosp, Dongguan, Peoples R China
[7] Air Force Med Univ, Dept Oncol Tangdu Hosp, Xian, Shaanxi, Peoples R China
[8] Jiangxi Canc Hosp, Dept Chest Oncol, Nanchang, Jiangxi, Peoples R China
[9] Shandong First Med Univ, Chemotherapy Dept, Oncol Ctr, Shandong Prov Hosp, Jinan, Peoples R China
[10] Guangxi Med Univ, Dept Oncol, Affiliated Hosp 1, Nanning, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China
[12] Anhui Chest Hosp, Oncol Radiotherapy Dept, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20106
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study
    Paz-Ares, L.
    Arriola, E.
    Campelo, M. R. Garcia
    Tain, M. P. Diz
    Blanco, M. C. Marti
    Vega, A. L. Moreno
    Leon-Mateos, L.
    Calderon, V. Gutierrez
    Hernandez, A. Sanchez
    Rodriguez, J. M. Oramas
    Majem, M.
    De la Rosa, C. Aguado
    Cabellos, R. Alvarez
    Ciriquian, J. L. Marti
    Amezcua, V.
    Perez, J. L. Firvida
    Mellen, A. Callejo
    Baez, L.
    Isla, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S1171 - S1172
  • [42] Second-line treatment outcomes following first-line chemotherapy plus immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter study.
    Pons-Tostivint, Elvire
    Ezzedine, Remy
    Goronflot, Thomas
    Crequit, Perrine
    Chatellier, Thierry
    Raimbourg, Judith
    Bennouna, Jaafar
    Leprieur, Etienne Giroux
    Porte, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] A comparative study on etoposide combined with lobaplatin or cisplatin in the first-line treatment of extensive-stage small cell lung cancer
    Li, Shujun
    Liang, Yahai
    Wu, Yanxia
    Huang, Zhong
    Lin, Yanming
    Yang, Zhixiong
    Chen, Hualin
    Wu, Aibing
    JOURNAL OF BUON, 2020, 25 (03): : 1490 - 1496
  • [44] Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practice
    Yang, Yaning
    Ai, Xin
    Xu, Haiyan
    Yang, Guangjian
    Yang, Lu
    Hao, Xuezhi
    Yang, Ke
    Mi, Yuling
    Wang, Guizhen
    Zhang, Shuyang
    Lei, Siyu
    Wang, Yan
    THORACIC CANCER, 2022, 13 (23) : 3295 - 3303
  • [45] IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer
    Huang, Chengliang
    Gan, Gregory N.
    Zhang, Jun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [46] Anlotinib Plus Standard Chemotherapy as First-line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
    Zhang, W.
    Yang, H.
    Kong, T.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S536 - S536
  • [47] Clinical efficacy of Camrelizumab combined with first-line chemotherapy in extensive-stage small-cell lung cancer
    Zhang, Dou
    Kong, Fanming
    Gao, Fangfang
    Li, Longhui
    Liang, Yangyueying
    Yu, Minghui
    Zhao, Lu
    Wang, Na
    Jia, Yingjie
    HELIYON, 2024, 10 (01)
  • [48] Anlotinib plus standard chemotherapy as first-line treatment in extensive-stage small cell lung cancer patients
    Zhang, W.
    Yang, H.
    Kong, T.
    Han, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1580 - S1580
  • [49] Prognostic implications of neutrophil-to-lymphocyte ratio in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real-world study
    Bi, Huanhuan
    Ren, Dunqiang
    Xiao, Yuting
    Zhou, Yinxue
    Yi, Bingqian
    Han, Weizhong
    Shao, Yanmei
    Wang, Jingluan
    Zhang, Chunling
    Wang, Hongmei
    THORACIC CANCER, 2024, 15 (07) : 559 - 569
  • [50] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
12345